Opportunity for Leadership in Predictive Biomarker Diagnostics for Pre-Eclampsia
Metabolomic Diagnostics (“MetaDx”; www.metabolomicdiagnostics.com) is a Cork, Ireland-based predictive biomarker diagnostics company with novel intellectual property and a breakthrough approach to predicting pre-eclampsia in pregnant women. It also has a pipeline of additional metabolomic biomarker tests for additional health issues faced by pregnant women and their babies, including pre-term birth. Sage Group is representing MetaDx in a search for one or more commercial part